Original Article

Sickle Cell Disease, More Than Just Pain: The Mediating Role of Psychological Symptoms

Authors: Mona A. Robbins, PhD, Lakeya S. McGill, MA, Breanna M. Holloway, BA, Shawn M. Bediako, PhD

Abstract

Objectives: Perceived stress is associated with sickle cell disease (SCD) pain; however, little is known about psychological mechanisms that may clarify this link among adult patients. This study explored whether anxiety and depression symptoms explained the relation between perceived stress and SCD pain episode frequency among 70 African-American adults (51.4% women, mean age 35.6 years).

Methods: Participants completed measures of perceived stress, pain, and psychological symptoms in an outpatient clinical setting.

Results: A serial multiple mediation model showed that psychological symptoms collectively reduced the association between perceived stress and SCD pain frequency (b = 0.116, P = 0.141). However, only the indirect effect of stress on pain frequency through anxiety symptoms was significant (b = 0.089).

Conclusions: Anxiety but not depression symptoms best explain the association between stress and SCD pain. Further research is needed to identify the specific components of negative affect that drive the experience of SCD pain.
Posted in: Hematology7

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010;38(4 suppl):S512-S521.
2. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease-life expectancy and risk factors for early death. N Engl J Med 1994;330:1639-1644.
3. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (Hb S) allele and sickle cell disease: a HuGE review. Am J Epidemiol 2000;151:839-845.
4. Pauling L, Itano HA, Singer SJ, et al. Sickle cell anemia: a molecular disease. Science 1949;110:543-548.
5. Bediako SM. Psychosocial aspects of sickle cell disease: a primer for African American psychologists. In: Neville HA, Tynes BM, Utsey SO, , eds. Handbook of African American Psychology. Thousand Oaks, CA:Sage Publications;2009;:417-427.
6. McGann PT, Nero AC, Ware RE. Clinical features of β-thalassemia and sickle cell disease. Adv Exp Med Biol 2017;1013:1-26.
7. Ballas SK. Defining the phenotypes of sickle cell disease. Hemoglobin 2011;35:511-519.
8
. Dampier C, LeBeau P, Rhee S, et al. Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. Am J Hematol 2011;86:203-205.
9. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364:1343-1360.
10. Gil KM, Carson JW, Porter LS, et al. Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease. Health Psychol 2004;23:267-274.
11. Levenson JL, McClish DK, Dahman BA, et al. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med 2008;70:192-196.
12. Porter LS, Gil KM, Carson JW, et al. The role of stress and mood in sickle cell disease pain: an analysis of daily diary data. J Health Psychol 2000;5:53-63.
13. Wallen GR, Minniti CP, Krumlauf M, et al. Sleep disturbance, depression and pain in adults with sickle cell disease. BMC Psychiatry 2014;14:207.
14. Gibson RC, Morgan KAD, Abel WD, et al. Locus of control, depression and quality of life among persons with sickle cell disease in Jamaica. Psychol Health Med 2013;18:451-460.
15. Imhonde HO, Ndom RJ, Ehon A. Social-support, self-esteem and depression as determinants of quality of life among sickle cell patients. IFE Psychologia 2013;21:101-113.
16. Grant MM, Gil KM, Floyd MY, et al. Depression and functioning in relation to health care use in sickle cell disease. Ann Behav Med 2000;22:149-157.
17. Thomas VJ, Gruen R, Shu S. Cognitive-behavioural therapy for the management of sickle cell disease pain: identification and assessment of costs. Ethnic Health 2001;6:59-67.
18. Alao AO, Cooley E. Depression and sickle cell disease. Harvard Rev Psychiat 2001;9:169-177.
19. Alao AO, Dewan MJ, Jindal S, et al. Psychopathology in sickle cell disease. W Afr J Med 2004;22:334-337.
20. Hasan SP, Hashmi S, Alhassen M, et al. Depression in sickle cell disease. J Natl Med Assoc 2003;95:533-537.
21. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-396.
22. Porter LS, Gil KM, Sedway JA, et al. Pain and stress in sickle cell disease: an analysis of daily pain records. Int J Behav Med 1998;5:185-203.
23. An K, Salyer J, Brown RE, et al. Salivary biomarkers of chronic psychosocial stress and CVD risks: a systematic review. Biol Res Nurs 2016;18:241-263.
24. Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 2004;130:601-630.
25. Edwards CL, Killough A, Wood M, et al. Emotional reactions to pain predict psychological distress in adult patients with sickle cell disease (SCD). Int J Psychiatry Med 2014;47:1-16.
26. Edwards CL, Green M, Wellington CC, et al. Depression, suicidal ideation, and attempts in black patients with sickle cell disease. J Nat Med Assoc 2009;101:1090-1095.
27. Molock SD, Belgrave FZ. Depression and anxiety in patients with sickle cell disease: conceptual and methodological considerations. J Health Soc Policy 1994;5:39-53.
28. Cohen S, Kessler RC, Gordon LU. Strategies for measuring stress in studies of psychiatric and physical disorders. In: Cohen S, Kessler RC, Gordon LU, , eds. Measuring Stress: A Guide for Health and Social Scientists. New York:Oxford University Press;1995;:3-26.
29. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-136.
30. Lazarus RS, Folkman S. Stress, Appraisal, and Coping. New York:Springer;1984.
31. Laurence B, George D, Woods D. Association between elevated depressive symptoms and clinical disease severity in African-American adults with sickle cell disease. J Natl Med Assoc 2006;98:365-369.
32. Mahdi N, Al-Ola K, Khalek NA, et al. Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis. J Pediatr Hematol Oncol 2010;32:345-349.
33. Barakat LP, Patterson CA, Daniel LC, et al. Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress. Health Qual Life Outcomes 2008;6:60.
34. Valrie CR, Gil KM, Redding-Lallinger R, et al. Daily mood as a mediator or moderator of the pain-sleep relationship in children with sickle cell disease. J Pediatr Psychol 2008;33:317-322.
35. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA 2007;298:1685-1687.
36. Ganzel BL, Morris PA, Wethington E. Allostasis and the human brain: integrating models of stress from the social and life sciences. Psychol Rev 2010;117:134-174.
37. Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary adrenocortical axis in humans. Psychol Bull 2007;133:25-45.
38. Mathews A, MacLeod C. Cognitive vulnerability to emotional disorders. Ann Rev Clin Psychol 2005;1:167-195.
39. Beck AT, Clark DA. Anxiety and depression: an information processing perspective. Anx Res 1988;1:23-36.
40. Bediako SM, Lattimer L, Haywood C, Jr et al. Religious coping and hospital admissions among adults with sickle cell disease. J Behav Med 2011;34:120-127.
41. Edwards R, Telfair J, Cecil H, et al. Self-efficacy as a predictor of adult adjustment to sickle cell disease:one-year outcomes. Psychosom Med 2001;63:850-858.
42. Derogatis LR. BSI Brief Symptom Inventory: Administration, Scoring, and Procedure Manual. Minneapolis, MN: National Computer Systems; 1993.
43. Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York: Guilford Press; 2013.
44. Wellington C, Edwards CL, McNeil J, et al. Somatization in the conceptualization of sickle cell disease. J Natl Med Assoc 2010;102:1079-1083.
45. Anie KA, Green J. Psychological therapies for sickle cell disease and pain. Cochrane Database Syst Rev 2015;5:CD001916.
46. Edwards LY, Edwards CL. Psychosocial treatments in pain management of sickle cell disease. J Natl Med Assoc 2010;102:1084-1094.
47. Abdullah T, Brown TL. Mental illness stigma and ethnocultural beliefs, values, and norms: an integrative review. Clin Psychol Rev 2011;31:934-948.
48. Jenerette C, Funk M, Murdaugh C. Sickle cell disease: a stigmatizing condition that may lead to depression. Issues Ment Health Nurs 2005;26:1081-1101.
49. Jonassaint CR, Jones VL, Leong S, et al. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haemotol 2016;174:136-147.